Bahram Chahardouli
Overview
Explore the profile of Bahram Chahardouli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
272
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Evaluation of Janus Kinase 2 Exon 12 Mutations in Patients With JAK2V617F-negative Polycythemia Vera
Khosravi S, Chahardouli B, Ebrahimi P, Babaei F, Alimoghadam K, Rostami S
Hematol Oncol Stem Cell Ther
. 2024 Apr;
17(2):154-158.
PMID: 38560972
No abstract available.
2.
Shokati A, Naser Moghadasi A, Ghashghaei A, Sahraian M, Chahardouli B, Mousavi S, et al.
Mol Biol Rep
. 2024 Mar;
51(1):460.
PMID: 38551770
Background: Among neurological diseases, multiple sclerosis (MS) affects mostly young adults and can cause long-term disability. While most medications with approval from regulatory agencies are very effective in treating MS...
3.
Joneidi Z, Mortazavi Y, Chahardouli B, Rostami S, Vaezi M, Nabipour M, et al.
Int J Hematol Oncol Stem Cell Res
. 2023 Dec;
17(4):281-290.
PMID: 38076777
Arsenic three oxide (As2O3) is the treatment choice for acute promyelocytic leukemia (APL). Little is known about possible risk factors with predictive value for toxicity caused by As2O3. Biomethylation is...
4.
Nekoeian S, Rostami T, Norouzy A, Hussein S, Tavoosidana G, Chahardouli B, et al.
Oncol Res
. 2023 Jun;
30(6):259-268.
PMID: 37303492
Acute lymphoblastic leukemia (ALL) is a malignancy of bone marrow lymphoid precursors. Despite effective treatments, the causes of its progression or recurrence are still unknown. Finding prognostic biomarkers is needed...
5.
Barkhordar M, Chahardouli B, Biglari A, Ahmadvand M, Bahri T, Alaeddini F, et al.
Front Immunol
. 2023 May;
14:1169666.
PMID: 37153556
Background: Allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients must be vaccinated against SARS-CoV-2 as quickly as possible after transplantation. The difficulty in obtaining recommended SARS-CoV-2 vaccines for allo-HSCT recipients motivated...
6.
Retrospective Evaluation of Hairy Cell Leukemia Patients: Analysis of a Long-Term Single Center Data
Biglari M, Kamranzadeh Foumani H, Bagherian M, Chahardouli B, Ghavamzadeh A
Int J Hematol Oncol Stem Cell Res
. 2023 Mar;
16(4):209-216.
PMID: 36883111
Hairy cell leukemia (HCL) is a distinct lymphoproliferative disorder with unique circulating lymphocyte morphology. It is now regarded as an indolent disease yet treatable with purine analogs. We are going...
7.
Pezeshki S, Jazayeri M, Chahardouli B, Tajik N, Nabavi S, Akbarzadeh M
Iran J Allergy Asthma Immunol
. 2023 Jan;
21(6):670-676.
PMID: 36640058
Chronic lymphocytic leukemia (CLL) is the clonal expansion of mature CD5+ B cells and the most common lymphoproliferative disease in adults (B1-CLL). B1 cells' anti-inflammatory effects include the production of...
8.
Kazemi-Sefat G, Keramatipour M, Vaezi M, Razavi S, Kavousi K, Talebi A, et al.
Sci Rep
. 2023 Jan;
13(1):736.
PMID: 36639723
No abstract available.
9.
Shirin M, Agharezaeei M, Alizadeh S, Bashash D, Sheikhsaran F, Chahardouli B, et al.
Asian Pac J Cancer Prev
. 2022 Sep;
23(9):3083-3092.
PMID: 36172671
Background: Mesenchymal stem cells (MSCs) have gained much more attention in cell therapy and regenerative medicine due to their immunosuppressive effects. MSCs have interaction with other immune cells, such as...
10.
Kazemi-Sefat G, Keramatipour M, Vaezi M, Razavi S, Kavousi K, Talebi A, et al.
Sci Rep
. 2022 Jul;
12(1):12816.
PMID: 35896598
Chronic myeloid leukemia (CML) is a model of leukemogenesis in which the exact molecular mechanisms underlying blast crisis still remained unexplored. The current study identified multiple common and rare important...